ClinicalTrials.Veeva

Menu

The Use of a Restrictive Fluid Regimen With Hypertonic Saline for Patients Undergoing Pancreaticoduodenectomy

Thomas Jefferson University logo

Thomas Jefferson University

Status and phase

Unknown
Phase 2

Conditions

Pancreaticoduodenectomy

Treatments

Drug: Lactated Ringers Solution
Drug: 3% NaCl Solution

Study type

Interventional

Funder types

Other

Identifiers

NCT01428050
Jefferson Hypertonic

Details and patient eligibility

About

The Whipple operation is a complex surgical procedure involving the removal of the head of the pancreas, bile duct, and a portion of the intestine (duodenum) that is performed for patients who have cancer or some other condition affecting this region of the body. The Whipple operation is associated with a significant complication rate. Previous studies have shown that in a broad range of surgical procedures, using a reduced amount of intravenous fluids along with a special type of fluid called hypertonic saline during and after the procedure can lower complication rates associated with the heart and lungs during recovery from surgery. The purpose of this study is to determine if using a reduced amount of intravenous fluids as well as hypertonic saline (a salt concentrated form of intravenous fluids) during the Whipple operation and in the immediate period after surgery can reduce complications.

Enrollment

264 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Physiologic suitability for major abdominal surgery
  • Aged 18 years and older
  • Written informed consent
  • Ability to understand and comply with study guidelines
  • Ability to obtain a central venous line

Exclusion criteria

  • Metabolic acidosis
  • Active Sepsis or Bacteremia
  • Chronic renal insufficiency
  • Hyponatremia (serum sodium <130)
  • Hypernatremia (serum sodium >150)
  • Pregnancy
  • Sickle cell anemia
  • Pediatric patients
  • BMI>40

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

264 participants in 2 patient groups

3% saline
Experimental group
Description:
Patients will received 3% saline in conjunction with lactated ringers solution intra and post operatively for a net reduction in total fluid administration
Treatment:
Drug: 3% NaCl Solution
Lactated Ringers
Active Comparator group
Description:
15cc/kg/hr of lactated ringers solution intraoperatively
Treatment:
Drug: Lactated Ringers Solution

Trial contacts and locations

1

Loading...

Central trial contact

Harish Lavu, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems